Anish Bhatnagar's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Aug 30, 2024
- Accession no.
- 0001415889-24-022648
- Filed
- Aug 30, 2024
- Trade date
- Aug 28-29, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.45M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anish BhatnagarCIK 0001614821 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2024 | Common Stock | SSaleDisposed | −30,262 | $47.19 | −$1,428,063.78 | 825,928 | Direct | |
| Aug 28, 2024 | Common Stock | SSaleDisposed | −26,351 | $48.03 | −$1,265,638.53 | 799,577 | Direct | |
| Aug 29, 2024 | Common Stock | SSaleDisposed | −47,551 | $47.16 | −$2,242,505.16 | 752,026 | Direct | |
| Aug 29, 2024 | Common Stock | SSaleDisposed | −10,840 | $47.83 | −$518,477.2 | 741,186 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.